Evangelisches Krankenhaus Hamm
Hospital
Location:
Hamm,
Germany (DE)
ISNI: 0000000406365983
ROR: https://ror.org/04x747113
Show on Map:
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017)
Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al.
Journal article
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015)
Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al.
Journal article
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial (2015)
Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, et al.
Journal article
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib (2014)
Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C, Fabarius A, et al.
Journal article